AMRI (Albany Molecular Research, Inc.) provides scientific services, products and technologies that improve quality of life while delivering excellence, value and maximum return. Its core business consists of a fee-for-service contract services platform encompassing drug discovery, development and manufacturing services, and a separate, strategic technology division consisting of proprietary technology investments, internal drug discovery and niche generic active pharmaceutical ingredient product development.
Founded in 1991 as Albany Molecular Research, Inc., AMRI (NASDAQ:AMRI), celebrates almost twenty years as a premier contract research and manufacturing organisation. With locations throughout the United States, Singapore, Hungary and Asia, AMRI is uniquely positioned in the marketplace to provide customers with a broad range of services, technologies, geographic proximity and cost models.
Services and Capabilities:
AMRI provides a broad spectrum of integrated chemistry and biology services backed by a highly experienced and educated and scientific staff. AMRI's tightly integrated services can be accessed independently or as a full drug discovery, manufacturing and development platform.
Discovery
AMRI helps customers identify and optimise biologically active compounds and also provides medicinal chemistry and lead optimisation support.
Development/Small Scale Manufacturing
AMRI provides a variety of key development services including the ability to scale-up compounds for preclinical testing and develop new synthetic routes to target compounds.
Large Scale Manufacturing
AMRI's large scale facilities provide manufacturing of APIs and advanced intermediates. Its U.S.-based commercial cGMP facility manufactures a number of customer compounds for both clinical trials and commercial products and provides specialised capabilities in the areas of high potency and controlled substance manufacturing.